Central Venous Catheterization in Patients with Coagulopathy

Safe Thresholds for Insertion without Correction

The American College of Anaesthesia recommends proceeding with central venous catheter (CVC) insertion without prophylactic correction of coagulation parameters if platelet count is ≥ 50 × 10⁹/L, INR ≤ 1.8, and TTPa ≤ 1.3 times the normal value 1
The American College of Anaesthesia suggests selecting a compressible insertion site, using real-time ultrasonographic guidance, assigning an experienced operator, and avoiding the subclavian site to minimize bleeding risk in patients with coagulopathy 1

In critically ill patients with coagulopathy, the American College of Internal Medicine recommends preferring peripherally inserted central catheters (PICCs) over CVCs if use will be >15 days, due to lower risk of insertion complications 2, 3
The National Comprehensive Cancer Network recommends not placing a CVC until coagulopathy is controlled in patients with acute promyelocytic leukemia (APL), due to the high risk of fatal hemorrhage, and maintaining platelets ≥50,000/μL and fibrinogen >150 mg/dL before any invasive procedure 4

The American College of Anaesthesia recommends applying firm digital pressure for at least 5 minutes, placing an occlusive dressing, administering blood products reactively, and considering skin suture if bleeding persists during or after CVC insertion 1

The American College of Anaesthesia suggests that prophylactic correction may be considered only in cases of severe thrombocytopenia <20 × 10⁹/L in non-compressible sites, extreme coagulopathy with active bleeding, or patients with APL until coagulopathy is controlled 1, 4